Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects

Brief Title

Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects

Official Title

Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects

Brief Summary

      The purpose of this study is to compare physical activity levels between patients with
      bronchiectasis and healthy subjects.

      We hypothesize that patients with bronchiectasis will have lower levels of physical activity,
      since physical activity levels is affected by reduced exercise tolerance, severity of disease
      and other disease related symptoms and conditions.

Detailed Description

      Physical activity limitation in chronic respiratory diseases is caused by many factors
      including respiratory, hemodynamic, and peripheral muscle weakness. Bronchiectasis is
      characterized by irreversible widening of the medium-sized airways, with inflammation,
      chronic bacterial infection and destruction of the bronchial walls. In addition to pulmonary
      function worsening, extra pulmonary features such as reduced peripheral muscle endurance can
      be a significant physical problem which causing a decrease in physical activity levels.

      Despite physical activity is considered to be essential for the management of chronic
      respiratory diseases, there is a lack of scientific study, which compares physical activity
      levels between patients with bronchiectasis and healthy subjects.

      This study will assess physical activity level, exercise capacity, quality of life and
      peripheral muscle strength in patients with bronchiectasis compared to healthy subjects.

Study Type

Observational

Primary Outcome

Number of steps on accelerometer

Secondary Outcome

 Shortness of breath using the Modified Medical Research Council Dyspnea Scale

Condition

Bronchiectasis

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Estimated Enrollment

Start Date

September 2015

Completion Date

August 2016

Primary Completion Date

August 2016

Eligibility Criteria

        Inclusion Criteria:

        Inclusion criteria of the Bronchiectasis Group:

          1. Diagnosis of bronchiectasis

          2. Being 18 years of age or older

          3. Able and willing to complete the informed consent process.

          4. Able to walk and co-operate

        Exclusion Criteria:

        Exclusion criteria of Bronchiectasis Group:

          1. Unstable medical condition

          2. To have severe neurological, orthopedic problems or severe heart failure.

        The control group will consist of healthy subjects.

Gender

All

Ages

18 Years - 65 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

ASLIHAN CAKMAK, ,

Location Countries

Turkey

Location Countries

Turkey

Administrative Informations

NCT ID

NCT02550821

Organization ID

GO 15/313

Responsible Party

Principal Investigator

Study Sponsor

Hacettepe University

Study Sponsor

ASLIHAN CAKMAK, Principal Investigator, Hacettepe University

Verification Date

September 2019